NDC 76045-009-10 Dilaudid
Hydromorphone Hydrochloride Injection, Solution Intramuscular; Intravenous; Subcutaneous
NDC Package Code 76045-009-10
The NDC Code 76045-009-10 is assigned to a package of 24 syringe in 1 carton > 1 ml in 1 syringe (76045-009-00) of Dilaudid, a human prescription drug labeled by Fresenius Kabi Usa, Llc. The product's dosage form is injection, solution and is administered via intramuscular; intravenous; subcutaneous form.This product is billed per "ML" milliliter and contains an estimated amount of 24 billable units per package.
NDC Code Structure
- 76045 - Fresenius Kabi Usa, Llc
- 76045-009 - Dilaudid
- 76045-009-10 - 24 SYRINGE in 1 CARTON
- 76045-009 - Dilaudid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 76045-009-10 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
76045000910 | J1170 | Hydromorphone injection | 4 MG | 1 | 24 | 0.25 | 6 |
* Please review the disclaimer below.
Other Product Packages
The following packages are also available for Dilaudid with product NDC 76045-009.
NDC Package Code | Package Description |
---|---|
76045-009-05 | 24 SYRINGE in 1 CARTON > .5 mL in 1 SYRINGE (76045-009-03) |
76045-009-06 | 10 SYRINGE in 1 CARTON > .5 mL in 1 SYRINGE (76045-009-96) |
76045-009-11 | 10 SYRINGE in 1 CARTON > 1 mL in 1 SYRINGE (76045-009-01) |
* Please review the disclaimer below.